Mignon M, Cadiot G (Bichat and Claude Bernard Hospital, Paris, France). Diagnostic and
therapeutic criteria in patients with Zollinger–Ellison syndrome and multiple endocrine …

Jensen RT (Bethesda, MD, USA). Management of the Zollinger–Ellison syndrome in patients
with multiple endocrine neoplasia type 1 (Minisymposium: MEN & VHL). J Intern Med 1998; …

The clinical evolution of type I multiple endocrine neoplasia (MEN I) was studied in 45
patients among a consecutive series of 172 with Zollinger-Ellison syndrome (ZES). These …

Background & Aims: Risk factors of metachronous liver metastases and death are not well
known in patients with the Zollinger–Ellison syndrome and multiple endocrine neoplasia …

Abstract purpose: To determine whether patients with multiple endocrine neoplasia type I
(MEN-I) can initially present with Zollinger-Ellison syndrome (ZES), and to learn whether …

In patients with multiple endocrine neoplasia type 1 (MEN1), the most common functional
pancreatic endocrine tumor (PET) syndrome is Zollinger-Ellison syndrome (ZES). ZES has …

Background. The long-term prognosis of Zollinger-Ellison Syndrome (ZES) is not well
defined. The findings of other endocrinopathies, the need for long-term surveillance, and the …

Background and Methods The role of surgery in patients with the Zollinger–Ellison
syndrome is controversial. To determine the efficacy of surgery in patients with this …

The role of surgery in the management of patients with sporadic (not part of multiple
endocrine neoplasia type 1) Zollinger–Ellison syndrome (ZES) is controversial. In this …

Objective: To determine the role of reoperation in patients with persistent or recurrent
Zollinger-Ellison Syndrome (ZES). Background: Approximately, 0% to 60% of ZES patients …